Drugs / PF-00885706
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00730665 | Jan → Oct 2008 | gastroesophageal reflux disease | Pfizer | Terminated | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | PF-00885706 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00730665 ↗ |
| Action | Activate | “PF-00885706, A 5-HT4 Receptor Partial Agonist” NCT00730665 ↗ |